¥4.10   ( %)
前日收盘: 当日成交量(股): 当日最高: 总股本:5601.03万
当日开盘: 当日成交额(元): 当日最低: 流通股本:
市盈率(动/静):0/0 市净率:0 市销率:0 总市值:2.30亿
52周最高:18.20 52周最低:3.95 转让方式: 单位:美元
$MELINTA THERAPEUTICS(MLNT)$
  • 还可以输入
  • 20016

MELINTA THERAPEUTICS(MLNT) 09月19日 00时02分

新闻 Melinta Therapeutics Names Peter Milligan as Chief Financial Officer
NEW HAVEN, Conn., Sept. 18, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage compa ......  url.vc.watch/JsvU
查看全文

MELINTA THERAPEUTICS(MLNT) 09月11日 07时23分

查看全文

MELINTA THERAPEUTICS(MLNT) 09月08日 15时12分

查看全文

MELINTA THERAPEUTICS(MLNT) 09月08日 15时12分

查看全文

MELINTA THERAPEUTICS(MLNT) 09月07日 01时32分

新闻 Melinta Therapeutics to Host Meetings at the Morgan Stanley 16th Annual Global Healthcare Conference
NEW HAVEN, Conn., Sept. 06, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ ......  url.vc.watch/jo5X
查看全文

MELINTA THERAPEUTICS(MLNT) 08月30日 02时05分

新闻 Melinta Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference
Melinta Therapeutics to Present at the Rodman & Renshaw 20th Annu ......  url.vc.watch/jRM4
查看全文

MELINTA THERAPEUTICS(MLNT) 08月24日 22时54分

查看全文

MELINTA THERAPEUTICS(MLNT) 08月24日 22时54分

查看全文

MELINTA THERAPEUTICS(MLNT) 08月16日 00时30分

新闻 Melinta Therapeutics to Report Second Quarter 2018 Financial Results on August 7, 2018
NEW HAVEN, Conn., July 11, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (N ......  url.vc.watch/jLOe
查看全文

MELINTA THERAPEUTICS(MLNT) 08月16日 00时30分

新闻 Melinta Therapeutics Announces Vabomere™ (meropenem and vaborbactam) Granted New Technology Add-On Payment by CMS Payment Will Reimburse up to 50% of Cost for Hospitals T ......  url.vc.watch/jLOS
查看全文

MELINTA THERAPEUTICS(MLNT) 08月16日 00时30分

新闻 Melinta Therapeutics Reports Second Quarter 2018 Financial Results
Solid Performance from New Product Launches VabomereTM Granted NTAP Status by CMS Strengthened ......  url.vc.watch/jLOZ
查看全文

MELINTA THERAPEUTICS(MLNT) 07月10日 23时04分

新闻 Melinta Therapeutics to Present Detailed Results from Vabomere TANGO II Trial as well as New In Vitro and In Vivo Findings from Baxdela and Pyrrolocytosine Candidate at E ......  url.vc.watch/E6ta
查看全文

MELINTA THERAPEUTICS(MLNT) 07月10日 23时04分

新闻 Melinta Therapeutics Presents Updates on the Pyrrolocytosine Compound RX-P2382 against ESKAPE Pathogens at ECCMID 2018 NEW HAVEN, Conn., April 23, 2018 (GLOBE NEWSWIRE) ......  url.vc.watch/E6th
查看全文

MELINTA THERAPEUTICS(MLNT) 07月10日 23时04分

新闻 Melinta Therapeutics Presents Results from VABOMERE TANGO II Trial at ECCMID 2018, Highlighting Outcomes in Vulnerable Patient Populations NEW HAVEN, Conn., April 23, 2 ......  url.vc.watch/E6tM
查看全文

MELINTA THERAPEUTICS(MLNT) 07月10日 23时04分

新闻 Melinta Therapeutics to Report First Quarter 2018 Financial Results on May 8, 2018
NEW HAVEN, Conn., April 27, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASD ......  url.vc.watch/E6tF
查看全文

MELINTA THERAPEUTICS(MLNT) 07月10日 23时04分

新闻 Melinta Therapeutics Receives Up to $6.2 Million from CARB-X to Advance Clinical Development of a Novel Antimicrobial to Combat Antibiotic-Resistant Bacteria NEW HAVEN, ......  url.vc.watch/E6t3
查看全文

MELINTA THERAPEUTICS(MLNT) 07月10日 23时04分

新闻 Melinta Therapeutics to Highlight Commitment to Antibiotics and Product Portfolio at MAD-ID 2018 Annual Meeting NEW HAVEN, Conn., May 08, 2018 (GLOBE NEWSWIRE) -- Melin ......  url.vc.watch/E6tR
查看全文

MELINTA THERAPEUTICS(MLNT) 07月10日 23时03分

新闻 Melinta Therapeutics Reports First Quarter 2018 Financial Results
Strong Product Sales Performance Across Entire Portfolio Continuing to Optimize Operations to Achiev ......  url.vc.watch/E6tV
查看全文

MELINTA THERAPEUTICS(MLNT) 07月10日 23时03分

新闻 Melinta Therapeutics Launches New Antibiotic Stewardship Program to Combat Growing Threat of Antimicrobial Resistance Part of Strong Company Presence at 2018 MAD-ID Annua ......  url.vc.watch/E6tS
查看全文

MELINTA THERAPEUTICS(MLNT) 07月10日 23时03分

新闻 Melinta Therapeutics Announces Proposed Offering of Common Stock
NEW HAVEN, Conn., May 21, 2018 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commerci ......  url.vc.watch/E6tK
查看全文
  • 首页 上一页 1 2 下一页 尾页  每页20条/共27